Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Adicionar filtros








Intervalo de ano
1.
Chinese Journal of Otorhinolaryngology Head and Neck Surgery ; (12): 200-203, 2013.
Artigo em Chinês | WPRIM | ID: wpr-315777

RESUMO

<p><b>OBJECTIVE</b>To evaluate the relationship between the Mandarin acceptable noise level (ANL) and the personality trait for normal-hearing adults.</p><p><b>METHODS</b>Eighty-five Mandarin speakers, aged from 21 to 27, participated in this study. ANL materials and the Eysenck Personality Questionnaire (EPQ) questionnaire were used to test the acceptable noise level and the personality trait for normal-hearing subjects. SPSS 17.0 was used to analyze the results.</p><p><b>RESULTS</b>ANL were (7.8 ± 2.9) dB in normal hearing participants. The P and N scores in EPQ were significantly correlated with ANL (r = 0.284 and 0.318, P < 0.01). No significant correlations were found between ANL and E and L scores (r = -0.036 and -.167, P > 0.05).</p><p><b>CONCLUSION</b>Listeners with higher ANL were more likely to be eccentric, hostile, aggressive, and instabe, no ANL differences were found in listeners who were different in introvert-extravert or lying.</p>


Assuntos
Adulto , Feminino , Humanos , Masculino , Adulto Jovem , Audiometria da Fala , Limiar Auditivo , Ruído , Personalidade
2.
Chinese Journal of Hepatology ; (12): 670-673, 2011.
Artigo em Chinês | WPRIM | ID: wpr-330665

RESUMO

<p><b>OBJECTIVE</b>To evaluate antiviral effects of Peg-IFNa-2a in patients with chronic hepatitis B.</p><p><b>METHODS</b>92 chronic hepatitis B patients were enrolled to receive the treatment with Peg-IFNa-2a 180 μg subcutaneous injection once weekly. The patients who did not get early response were divided into 3 groups: group 1, extend the treatment to 72 weeks; group 2, combined with nucleus(s)ide analogue (entecavir or adefovir) treatment; group 3, continue the treatment until 48 weeks. HBV DNA and quantitative HBsAg were assessed at baseline, week 12, 24, 36 and after 24 weeks follow-up.</p><p><b>RESULTS</b>Patients in group 1 had significantly higher SVR rate (78.3%) than patients in group 3 (38.1%, X2=7.33, P<0.05). The mean reduction of HBsAg in group 1 at 24 weeks of post-treatment follow up was higher than that in group 3 (t=2.11, P<0.05). In group 2 the mean reductions of HBV DNA at 24 weeks of post-treatment follow up were (3.9+/-1.1) log10 copy/ml and (3.7+/-1.3) log10 copy/ml respectively with combination of entecavir or adefovir, both of which were significantly higher than that in group 3(t=8.45 and 6.31, P<0.05); the SVR rates in the entecavir group and the adefovir group (83.3% and 85.7%, respectively) were significantly higher than that in group 3 (X2=8.20 and 7.78, P<0.05); the mean reductions of HBsAg in the entecavir group and the adefovir group [(0.8+/-0.5) log10 IU/ml and (0.9+/-0.3) log10 IU/ml, respectively ] were significantly greater than group 3[(0.4+/-0.3) log10 IU/ml, t=3.05 and 4.58, P<0.05]. The level of HBV DNA and C genotype were the main predictors of response.</p><p><b>CONCLUSION</b>Individualizing therapy by prolonging the duration of Peg-IFNa-2a treatment to 72 weeks or adding nucleoside analogues such as entecavir and adefovir in patients without early response may substantially increase the SVR rate and lead to the decrease of HBsAg.</p>


Assuntos
Adulto , Feminino , Humanos , Masculino , Pessoa de Meia-Idade , Adenina , Usos Terapêuticos , Antivirais , Usos Terapêuticos , Guanina , Usos Terapêuticos , Hepatite B Crônica , Tratamento Farmacológico , Interferon-alfa , Usos Terapêuticos , Organofosfonatos , Usos Terapêuticos , Resultado do Tratamento
3.
Chinese Journal of Preventive Medicine ; (12): 1000-1003, 2009.
Artigo em Chinês | WPRIM | ID: wpr-316079

RESUMO

<p><b>OBJECTIVE</b>To investigate the social health status of the HIV infected and their families in a high HIV/AIDS prevalence village in Hunan province and to examine the relations of the social health status, responses and social support.</p><p><b>METHODS</b>A total of 51 HIV infected persons (infected group), 49 family members of the infected (family member group) and 96 normal persons (control group) were surveyed by Social Health Measurement Scale-a sub-scale of Self-rated Health Measurement Scale (SRHMS), Social Support Assessment Scale (SSAS) and Trait Coping Style Questionnaire (TCSQ).</p><p><b>RESULTS</b>(1) In regard to the total scores of social health, responding style and social support, significant differences were found among the infected group, the group of family members and the control group (62.9 +/- 18.6, 79.8 +/- 18.0, 86.5 +/- 21.3, F = 18.16; 28.7 +/- 4.3, 27.2 +/- 5.4, 25.9 +/- 6.4, F = 5.21; 33.8 +/- 8.1, 41.0 +/- 6.6, 38.1 +/- 6.8, F = 13.23; P < 0.01). (2) Subjective care and support, the educational status, the marital status and support utilization were significant predictors to the social health status of the infected group (R(2) = 0.73, F = 27.78, P < 0.01). (3) Subjective support and negative responding style were significant predictors to the social health status of the group of family members (R(2) = 0.32, F = 12.35, P < 0.01).</p><p><b>CONCLUSION</b>The HIV infected and their families have more negative responding style, make less use of social support and hold a inferior social health status. It's necessary to exert psychological intervention targeting at these population group.</p>


Assuntos
Adolescente , Adulto , Idoso , Feminino , Humanos , Masculino , Pessoa de Meia-Idade , Adulto Jovem , Estudos de Casos e Controles , China , Família , Psicologia , Infecções por HIV , Psicologia , Nível de Saúde , Estudos de Amostragem , Apoio Social , Inquéritos e Questionários
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA